Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions
Background: Endometrial proliferative lesions (EPL) usually refer to endometrial hyperplasia (EH) and endometrial cancer (EC). Among patients with premenopausal EPL who wish to preserve their fertility, only those with EH and early-stage EC have the possibility to undergo fertility preservation ther...
Main Authors: | Yingsha Yao, Liujing Shi, Xiaoming Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/21/3301 |
Similar Items
-
Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
by: Nathalie di Clemente, et al.
Published: (2022-10-01) -
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01) -
Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
by: Mozhgan Kohzadi, et al.
Published: (2020-04-01) -
Correlation of phenotypes of polycystic ovarian syndrome with anti-Müllerian hormone levels
by: R Santhiya, et al.
Published: (2021-01-01) -
Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: Correlation with clinical, hormonal and ultrasonographic parameters
by: Adel F. Begawy, et al.
Published: (2010-10-01)